Hugo Mark Horlings

40PUBLICATIONS
320CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jun 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Feb 18, 2026
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC.

Noah F Greenwald, Iris Nederlof, Cameron Sowers

|Feb 09, 2026
Single-Cell Spatial Atlas of High-Grade Serous Ovarian Cancer Uncovers MHC Class II as a Key Predictor of Spatial Tumor Ecosystems and Clinical Outcomes.

Fernando Perez-Villatoro, Aleksandra Shabanova, Lilian van Wagensveld

|Feb 05, 2026
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group.

Ylva A Weeda, Roberto Salgado, Filip van Herpe

|Dec 10, 2025
Fasting boosts breast cancer therapy efficacy via glucocorticoid activation.

Nuno Padrão, Tesa M Severson, Sebastian Gregoricchio

Pageof 7

Frequent Collaborators

13 joint publications

Marleen Kok

11 joint publications

Koen Van de Vijver

9 joint publications

Roberto Salgado

7 joint publications

Joyce Sanders